2 Result: Abcam
Breaking: Abcam to be Acquired by Danaher; Setback for NovoCure
August 28th, 2023
Abcam plc (Nasdaq: ABCM) has agreed to be acquired by Danaher Corporation (NYSE: DHR) for $24.00 per share in cash. The transaction has received unanimous approval from both Abcam's and Danaher's Boards of Directors. In pre-market, $ABCM is tra. Read more
Lucintel Forecasts Epigenetic Market to grow at a CAGR of 14% from 2019 to 2024
December 08th, 2021
Dallas, TX / CRWE PRESS RELEASE / Dec. 9, 2021 - According to the recent study the Epigenetic Market is projected to grow at a CAGR of 14% from 2019 to 2024. Growth in this market is primarily driven by declining sequencing costs and time, incre. Read more
Want To Find Some News?
News By Industries
Recent Post
-
December 05th, 2025
FDA Approves Nerve Scaffold for the Treatment of Sensory Nerve Discontinuity
December 04th, 2025December 02nd, 2025Earnings Countdown: Salesforce, Snowflake, and Guidewire Take Center Stage
November 30th, 2025Wall Street Eyes CrowdStrike, Marvell Technology, and GitLab as Earnings Near
November 30th, 2025
Member Login